Emergent Historical Financial Ratios

EBS Stock

USD 4.61 0.31 6.30%

Emergent Biosolutions is recently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.0 or Days Sales Outstanding of 52.85 will help investors to properly organize and evaluate Emergent Biosolutions financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

About Emergent Financial Ratios Analysis

Emergent BiosolutionsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Emergent Biosolutions investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Emergent financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Emergent Biosolutions history.

Emergent Biosolutions Financial Ratios Chart

At this time, Emergent Biosolutions' Days Payables Outstanding is comparatively stable compared to the past year. EV To Free Cash Flow is likely to gain to 31.41 in 2025, whereas PTB Ratio is likely to drop 1.00 in 2025.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Emergent Biosolutions stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Emergent Biosolutions sales, a figure that is much harder to manipulate than other Emergent Biosolutions multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Emergent Biosolutions dividend as a percentage of Emergent Biosolutions stock price. Emergent Biosolutions dividend yield is a measure of Emergent Biosolutions stock productivity, which can be interpreted as interest rate earned on an Emergent Biosolutions investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Emergent Biosolutions' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Emergent Biosolutions current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.At this time, Emergent Biosolutions' Days Payables Outstanding is comparatively stable compared to the past year. EV To Free Cash Flow is likely to gain to 31.41 in 2025, whereas PTB Ratio is likely to drop 1.00 in 2025.

	2024	2025 (projected)
Dividend Yield	0.0202	0.018
Price To Sales Ratio	0.5	0.47

Dividend Yield Price To Sales Ratio

Emergent Biosolutions fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.48	-0.19	0.54	-0.15	0.53	0.66	0.23	-0.19	0.95	0.6	0.62	0.18	0.63	-0.51	0.01	0.53	-0.19	0.4	0.03	0.47	0.4	-0.16	-0.51	0.48	0.67
Dividend Yield	0.48		0.03	0.11	0.3	-0.11	0.15	0.35	0.03	0.4	0.02	0.28	0.66	0.24	-0.95	0.6	0.12	0.24	0.03	0.15	1.0	0.08	-0.1	-0.95	0.51	0.34
Ptb Ratio	-0.19	0.03		-0.92	0.65	-0.05	-0.56	-0.02	1.0	-0.3	-0.11	0.26	0.12	0.27	-0.03	0.03	-0.93	0.38	0.39	-0.05	0.03	0.12	-0.14	-0.03	0.16	0.2
Days Sales Outstanding	0.54	0.11	-0.92		-0.61	0.27	0.76	0.06	-0.92	0.63	0.37	0.02	-0.1	0.03	-0.12	-0.04	1.0	-0.39	-0.16	0.03	0.11	0.06	0.06	-0.12	0.01	0.09
Book Value Per Share	-0.15	0.3	0.65	-0.61		-0.03	-0.17	-0.17	0.65	-0.17	0.04	0.32	0.13	0.32	-0.32	0.61	-0.59	0.77	-0.04	-0.27	0.29	-0.34	-0.02	-0.32	0.14	0.29
Free Cash Flow Yield	0.53	-0.11	-0.05	0.27	-0.03		0.57	0.18	-0.05	0.45	0.67	0.85	-0.13	0.83	0.12	-0.42	0.27	0.11	0.18	0.06	-0.11	0.21	-0.04	0.12	0.29	0.85
Operating Cash Flow Per Share	0.66	0.15	-0.56	0.76	-0.17	0.57		0.0	-0.56	0.68	0.86	0.46	-0.1	0.53	-0.16	-0.01	0.77	-0.02	-0.19	-0.12	0.15	0.06	0.12	-0.16	0.31	0.48
Capex To Depreciation	0.23	0.35	-0.02	0.06	-0.17	0.18	0.0		-0.02	0.03	-0.07	0.33	0.61	0.3	-0.37	-0.3	0.06	-0.07	0.28	0.92	0.34	0.63	0.06	-0.37	0.21	0.37
Pb Ratio	-0.19	0.03	1.0	-0.92	0.65	-0.05	-0.56	-0.02		-0.3	-0.11	0.26	0.12	0.27	-0.03	0.03	-0.93	0.38	0.39	-0.05	0.03	0.12	-0.14	-0.03	0.16	0.2
Ev To Sales	0.95	0.4	-0.3	0.63	-0.17	0.45	0.68	0.03	-0.3		0.54	0.47	0.0	0.49	-0.42	0.1	0.61	-0.26	0.39	-0.12	0.39	0.27	-0.1	-0.42	0.32	0.52
Free Cash Flow Per Share	0.6	0.02	-0.11	0.37	0.04	0.67	0.86	-0.07	-0.11	0.54		0.63	-0.15	0.71	-0.02	-0.17	0.38	0.1	-0.09	-0.18	0.02	0.11	0.09	-0.02	0.46	0.61
Roic	0.62	0.28	0.26	0.02	0.32	0.85	0.46	0.33	0.26	0.47	0.63		0.19	0.98	-0.3	-0.12	0.03	0.38	0.28	0.11	0.27	0.29	-0.14	-0.3	0.49	0.99
Inventory Turnover	0.18	0.66	0.12	-0.1	0.13	-0.13	-0.1	0.61	0.12	0.0	-0.15	0.19		0.14	-0.7	0.21	-0.09	0.16	-0.01	0.41	0.65	0.17	0.06	-0.7	0.56	0.24
Net Income Per Share	0.63	0.24	0.27	0.03	0.32	0.83	0.53	0.3	0.27	0.49	0.71	0.98	0.14		-0.26	-0.14	0.04	0.34	0.31	0.09	0.24	0.36	-0.12	-0.26	0.49	0.97
Days Of Inventory On Hand	-0.51	-0.95	-0.03	-0.12	-0.32	0.12	-0.16	-0.37	-0.03	-0.42	-0.02	-0.3	-0.7	-0.26		-0.64	-0.12	-0.28	-0.06	-0.15	-0.93	-0.08	0.1	1.0	-0.54	-0.36
Payables Turnover	0.01	0.6	0.03	-0.04	0.61	-0.42	-0.01	-0.3	0.03	0.1	-0.17	-0.12	0.21	-0.14	-0.64		-0.03	0.44	-0.29	-0.41	0.59	-0.5	0.01	-0.64	0.12	-0.1
Capex To Revenue	0.53	0.12	-0.93	1.0	-0.59	0.27	0.77	0.06	-0.93	0.61	0.38	0.03	-0.09	0.04	-0.12	-0.03		-0.36	-0.19	0.03	0.11	0.04	0.07	-0.12	0.02	0.09
Cash Per Share	-0.19	0.24	0.38	-0.39	0.77	0.11	-0.02	-0.07	0.38	-0.26	0.1	0.38	0.16	0.34	-0.28	0.44	-0.36		-0.29	-0.19	0.23	-0.44	-0.18	-0.28	0.03	0.35
Pocfratio	0.4	0.03	0.39	-0.16	-0.04	0.18	-0.19	0.28	0.39	0.39	-0.09	0.28	-0.01	0.31	-0.06	-0.29	-0.19	-0.29		0.22	0.03	0.73	-0.27	-0.06	-0.1	0.29
Interest Coverage	0.03	0.15	-0.05	0.03	-0.27	0.06	-0.12	0.92	-0.05	-0.12	-0.18	0.11	0.41	0.09	-0.15	-0.41	0.03	-0.19	0.22		0.14	0.55	0.09	-0.15	0.06	0.15
Payout Ratio	0.47	1.0	0.03	0.11	0.29	-0.11	0.15	0.34	0.03	0.39	0.02	0.27	0.65	0.24	-0.93	0.59	0.11	0.23	0.03	0.14		0.08	-0.1	-0.93	0.5	0.33
Capex To Operating Cash Flow	0.4	0.08	0.12	0.06	-0.34	0.21	0.06	0.63	0.12	0.27	0.11	0.29	0.17	0.36	-0.08	-0.5	0.04	-0.44	0.73	0.55	0.08		-0.09	-0.08	0.12	0.3
Pfcf Ratio	-0.16	-0.1	-0.14	0.06	-0.02	-0.04	0.12	0.06	-0.14	-0.1	0.09	-0.14	0.06	-0.12	0.1	0.01	0.07	-0.18	-0.27	0.09	-0.1	-0.09		0.1	0.16	-0.13
Days Payables Outstanding	-0.51	-0.95	-0.03	-0.12	-0.32	0.12	-0.16	-0.37	-0.03	-0.42	-0.02	-0.3	-0.7	-0.26	1.0	-0.64	-0.12	-0.28	-0.06	-0.15	-0.93	-0.08	0.1		-0.54	-0.36
Income Quality	0.48	0.51	0.16	0.01	0.14	0.29	0.31	0.21	0.16	0.32	0.46	0.49	0.56	0.49	-0.54	0.12	0.02	0.03	-0.1	0.06	0.5	0.12	0.16	-0.54		0.52
Roe	0.67	0.34	0.2	0.09	0.29	0.85	0.48	0.37	0.2	0.52	0.61	0.99	0.24	0.97	-0.36	-0.1	0.09	0.35	0.29	0.15	0.33	0.3	-0.13	-0.36	0.52

Click cells to compare fundamentals

Emergent Biosolutions Account Relationship Matchups

Emergent Biosolutions fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	3.04	1.3	0.53	0.12	0.5	0.47
Ptb Ratio	3.26	1.44	0.43	0.19	1.05	1.0
Days Sales Outstanding	54.18	56.79	51.84	66.44	55.64	52.85
Book Value Per Share	27.46	30.26	27.6	12.68	9.11	10.27
Free Cash Flow Yield	0.0837	0.0413	(0.25)	(2.1)	0.0707	0.0742
Operating Cash Flow Per Share	10.17	6.0	(0.68)	(4.03)	1.11	1.05
Stock Based Compensation To Revenue	0.0333	0.0237	0.0402	0.022	0.0178	0.0169
Pb Ratio	3.26	1.44	0.43	0.19	1.05	1.0
Ev To Sales	3.2	1.45	1.21	0.83	1.06	1.0
Free Cash Flow Per Share	7.5	1.8	(2.99)	(5.04)	0.68	0.77
Roic	0.13	0.099	(0.0579)	(0.48)	(0.12)	(0.11)
Inventory Turnover	1.95	1.71	2.16	1.97	2.14	0.0
Net Income Per Share	5.8	4.1	(4.47)	(14.85)	(3.6)	(3.42)
Days Of Inventory On Hand	213.85	169.03	185.1	170.19	113.8B	119.5B
Payables Turnover	4.57	3.85	5.88	6.7	6.29	0.0
Research And Ddevelopement To Revenue	0.2	0.15	0.13	0.11	0.0698	0.0663
Cash Per Share	11.79	10.77	13.0	2.18	1.88	3.7
Pocfratio	8.81	7.24	(17.35)	(0.6)	8.63	16.6
Interest Coverage	13.86	10.22	(4.45)	(8.26)	(1.53)	(1.45)
Pfcf Ratio	11.95	24.2	(3.95)	(0.48)	14.15	14.86
Days Payables Outstanding	94.8	62.11	54.46	58.06	22.2B	23.3B
Roe	0.21	0.14	(0.16)	(1.17)	(0.39)	(0.38)
Ev To Operating Cash Flow	9.28	8.07	(39.73)	(4.22)	18.24	16.28
Pe Ratio	15.44	10.6	(2.64)	(0.16)	(2.66)	(2.53)
Return On Tangible Assets	0.16	0.1	(0.1)	(0.61)	(0.21)	(0.2)
Ev To Free Cash Flow	12.6	26.96	(9.04)	(3.38)	29.91	31.41
Earnings Yield	0.0196	0.0648	0.0944	(0.38)	(6.19)	(0.39)
Intangibles To Total Assets	0.32	0.28	0.3	0.31	0.36	0.34
Net Debt To E B I T D A	0.46	0.58	(23.2)	(1.48)	15.29	16.05
Tangible Book Value Per Share	9.81	14.76	8.7	1.62	(0.35)	(0.34)
Receivables Turnover	6.74	6.43	7.04	5.49	6.56	7.17
Shareholders Equity Per Share	27.46	30.26	27.6	12.68	9.11	10.26
Debt To Equity	0.6	0.52	1.02	1.32	1.37	1.44
Capex Per Share	2.68	4.21	2.31	1.01	0.43	0.41

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Emergent Historical Financial Ratios

About Emergent Financial Ratios Analysis

Emergent Biosolutions Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ev To Sales

Emergent Biosolutions fundamentals Correlations

Emergent Biosolutions Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Emergent Biosolutions fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Emergent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Payout Ratio	+ 1.0	Dividend Yield
Pb Ratio	+ 1.0	Ptb Ratio
Capex To Revenue	+ 1.0	Days Sales Outstanding
Days Payables Outstanding	+ 1.0	Days Of Inventory On Hand
Roe	+ 0.99	Roic
Net Income Per Share	+ 0.98	Roic

Days Payables Outstanding	- 0.95	Dividend Yield
Days Of Inventory On Hand	- 0.95	Dividend Yield
Days Payables Outstanding	- 0.93	Payout Ratio
Payout Ratio	- 0.93	Days Of Inventory On Hand
Capex To Revenue	- 0.93	Pb Ratio
Capex To Revenue	- 0.93	Ptb Ratio